NL-OMON24917招募中不适用
Phase II trial of the combination of gemcitabine and 131I-MIBG therapy in paediatric patients with relapsed or progressive neuroblastoma.
Academisch Medisch Centrum Amsterdam0 个研究点目标入组 66 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 66
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Histological proven neuroblastoma;
- •2. Measurable primary and/or metastatic disease;
排除标准
- •1. Received treatment within the last 21 days with an
- •investigational or conventional anti-cancer drug;
研究者
相似试验
已完成
2 期
Phase II trial of the combination of gemcitabine and 131I-MIBG therapy in paediatric patients with relapsed or progressive neuroblastomaNL-OMON39557Academisch Medisch Centrum16
进行中（未招募）
不适用
A phase II study of the combination of gemcitabine with 131I-MIBG therapy for children with neuroblastoma without other treatment options.relapsed or progressive neuroblastoma in pediatric patients of 1 to 18 yearsEUCTR2007-007974-45-NLAMC47
未知
1 期
Phase 1/2 study of the combination of gemcitabine and nedaplation for treatment of previously untreated advanced squamous cell lung cancerPreaviously untreated advanced advanced squamous cell lung cancerJPRN-C000000439Department of Respiratory Medicine of Kyoto University Hospital32
已完成
2 期
Combination of Gemcitabine and Imatinib Mesylate in Pemetrexed-pretreated Patients With Pleural MesotheliomaMesothelioma, MalignantNCT02303899Istituto Clinico Humanitas22
进行中（未招募）
1 期
Phase 2 single-arm studies of gemcitabine in combination with oxaliplatin in refractory and relapsed pediatric solid tumors. - ITCC-004-GEMOXRefractory or relapsing malignant pediatric solid tumors.EUCTR2006-001065-41-GBniversity Hospitals of Leicester NHS Trust, Research and Development Directorate156